[HTML][HTML] The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma

B Gok Yavuz, S Datar, S Chamseddine, YI Mohamed… - Cancers, 2023 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is the most common type of liver cancer,
accounting for approximately 85–90% of all cases of liver cancer worldwide. The gut …

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma

BG Yavuz, S Datar, S Chamseddine… - …, 2023 - pubmed.ncbi.nlm.nih.gov
The microbiome is pivotal in maintaining health and influencing disease by modulating
essential inflammatory and immune responses. Hepatocellular carcinoma (HCC), ranking as …

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.

B Gok Yavuz, S Datar, S Chamseddine… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: Hepatocellular carcinoma (HCC) is the most common type of liver
cancer, accounting for approximately 85–90% of all cases of liver cancer worldwide. The gut …

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma

BG Yavuz, S Datar, S Chamseddine, YI Mohamed… - …, 2023 - search.proquest.com
The microbiome is pivotal in maintaining health and influencing disease by modulating
essential inflammatory and immune responses. Hepatocellular carcinoma (HCC), ranking as …

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.

S Datar, S Chamseddine, YI Mohamed, M LaPelusa… - Cancers, 2023 - europepmc.org
The microbiome is pivotal in maintaining health and influencing disease by modulating
essential inflammatory and immune responses. Hepatocellular carcinoma (HCC), ranking as …

[HTML][HTML] The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma

BG Yavuz, S Datar, S Chamseddine, YI Mohamed… - Cancers, 2023 - ncbi.nlm.nih.gov
The microbiome is pivotal in maintaining health and influencing disease by modulating
essential inflammatory and immune responses. Hepatocellular carcinoma (HCC), ranking as …

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.

BG Yavuz, S Datar, S Chamseddine, YI Mohamed… - Cancers, 2023 - go.gale.com
Hepatocellular carcinoma (HCC) is the most common type of liver cancer, accounting for
approximately 85–90% of all cases of liver cancer worldwide. The gut microbiome can serve …

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma

BG Yavuz, S Datar, S Chamseddine, YI Mohamed… - 2023 - preprints.org
The microbiome is pivotal in maintaining health and influencing disease by modulating
essential inflammatory and immune responses. Hepatocellular carcinoma (HCC), ranking as …

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma

BG Yavuz, S Datar, S Chamseddine… - …, 2023 - mdanderson.elsevierpure.com
The microbiome is pivotal in maintaining health and influencing disease by modulating
essential inflammatory and immune responses. Hepatocellular carcinoma (HCC), ranking as …

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.

S Datar, S Chamseddine, YI Mohamed, M LaPelusa… - Cancers, 2023 - europepmc.org
The microbiome is pivotal in maintaining health and influencing disease by modulating
essential inflammatory and immune responses. Hepatocellular carcinoma (HCC), ranking as …